Phosphodiesterase type 5 inhibitors usage and prostate cancer: a match-paired analysis.

Transl Androl Urol · 2017 · PMC5673806 · PMID 29184786

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In this study, there was some evidence of an inverse trend between PDE5i use and prostate cancer—however, this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.